Home Healthcare Pharmaceuticals Dermatological Therapeutics Market

Dermatological Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin inhibitors, Retinoids, Others), By Applications (Alopecia, Herpes, Psoriasis, Rosacea, Atopic dermatitis, Acne vulgaris, Other applications) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Dermatological Therapeutics Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Anti-infectives
    2. Corticosteroids
    3. Anti-acne
    4. Calcineurin inhibitors
    5. Retinoids
    6. Others
  2. Dermatological Therapeutics Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Alopecia
    2. Herpes
    3. Psoriasis
    4. Rosacea
    5. Atopic dermatitis
    6. Acne vulgaris
    7. Other applications
  3. Regional Dermatological Therapeutics Market
    1. North America
      1. North America Dermatological Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
      2. North America Dermatological Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alopecia
        2. Herpes
        3. Psoriasis
        4. Rosacea
        5. Atopic dermatitis
        6. Acne vulgaris
        7. Other applications
      3. U.S.
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      4. Canada
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
    2. Europe
      1. Europe Dermatological Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
      2. Europe Dermatological Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alopecia
        2. Herpes
        3. Psoriasis
        4. Rosacea
        5. Atopic dermatitis
        6. Acne vulgaris
        7. Other applications
      3. U.K.
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      4. Germany
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      5. France
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      6. Spain
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      7. Italy
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      8. Russia
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      9. Nordic
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      10. Benelux
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      11. Rest of Europe
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
    3. APAC
      1. APAC Dermatological Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
      2. APAC Dermatological Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alopecia
        2. Herpes
        3. Psoriasis
        4. Rosacea
        5. Atopic dermatitis
        6. Acne vulgaris
        7. Other applications
      3. China
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      4. Korea
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      5. Japan
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      6. India
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      7. Australia
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      8. Singapore
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      9. Taiwan
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      10. South East Asia
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      11. Rest of Asia-Pacific
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
    4. Middle East and Africa
      1. Middle East and Africa Dermatological Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
      2. Middle East and Africa Dermatological Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alopecia
        2. Herpes
        3. Psoriasis
        4. Rosacea
        5. Atopic dermatitis
        6. Acne vulgaris
        7. Other applications
      3. UAE
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      4. Turkey
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      5. Saudi Arabia
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      6. South Africa
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      7. Egypt
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      8. Nigeria
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      9. Rest of MEA
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
    5. LATAM
      1. LATAM Dermatological Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
      2. LATAM Dermatological Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alopecia
        2. Herpes
        3. Psoriasis
        4. Rosacea
        5. Atopic dermatitis
        6. Acne vulgaris
        7. Other applications
      3. Brazil
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      4. Mexico
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      5. Argentina
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      6. Chile
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      7. Colombia
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
      8. Rest of LATAM
        1. Anti-infectives
        2. Corticosteroids
        3. Anti-acne
        4. Calcineurin inhibitors
        5. Retinoids
        6. Others
        7. Alopecia
        8. Herpes
        9. Psoriasis
        10. Rosacea
        11. Atopic dermatitis
        12. Acne vulgaris
        13. Other applications
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.